Logo image
Veteran-derived cerebral organoids display multifaceted pathological defects in studies on Gulf War Illness
Journal article   Open access   Peer reviewed

Veteran-derived cerebral organoids display multifaceted pathological defects in studies on Gulf War Illness

Philip Yates, Kendra Case, Xiaohuan Sun, Kimberly Sullivan, Peter Baas and Liang Qiang
Frontiers in cellular neuroscience, v 16
23 Dec 2022
url
https://doi.org/10.1523/eneuro.0178-22.2022View
Published, Version of Record (VoR)CC BY-NC-SA V4.0 Open
url
https://doi.org/10.3389/fncel.2022.979652View
Published, Version of Record (VoR) Open

Abstract

Allografts Animal cognition Animal models Brain Cell differentiation Cognitive ability Diisopropyl fluorophosphate Disease Glass substrates Growth factors Gulf War Gulf War syndrome Hormones Hydrocortisone Leukocytes (mononuclear) Military personnel Nerve agents Neurogenesis Organoids Organophosphates Organophosphorus pesticides Pathology Peripheral blood mononuclear cells Persian Gulf War Phenotypes Phosphorylation Pluripotency Rodents Sarin Stem cell transplantation Stem cells Tau protein Toxicants Veterans War
Approximately 30% of the veterans who fought in the 1991 Gulf War (GW) suffer from a disease called Gulf War Illness (GWI), which encompasses a constellation of symptoms including cognitive deficits. A coalescence of evidence indicates that GWI was caused by low-level exposure to organophosphate pesticides and nerve agents in combination with physical stressors of the battlefield. Until recently, progress on mechanisms and therapy had been limited to rodent-based models. Using peripheral blood mononuclear cells from veterans with or without GWI, we recently developed a bank of human induced pluripotent stem cells that can be differentiated into a variety of cellular fates. With these cells, we have now generated cerebral organoids, which are three-dimensional multicellular structures that resemble the human brain. We established organoid cultures from two GW veterans, one with GWI and one without. Immunohistochemical analyses indicate that these organoids, when treated with a GW toxicant regimen consisting of the organophosphate diisopropyl fluorophosphate (a sarin analog) and cortisol (to mimic battlefield stress), display multiple indicators consistent with cognitive deficits, including increased astrocytic reactivity, enhanced phosphorylation of tau proteins, decreased microtubule stability, and impaired neurogenesis. Interestingly, some of these phenotypes were more pronounced in the organoids derived from the veteran with GWI, potentially reflecting a stronger response to the toxicants in some individuals compared to others. These results suggest that veteran-derived human cerebral organoids not only can be used as an innovative human model to uncover the cellular responses to GW toxicants but can also serve as a platform for developing personalized medicine approaches for the veterans.

Metrics

16 Record Views
5 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Neurosciences
Logo image